Alpha Cognition (NASDAQ:ACOG) Given “Buy” Rating at HC Wainwright

HC Wainwright reiterated their buy rating on shares of Alpha Cognition (NASDAQ:ACOG) in a report released on Friday,Benzinga reports. They currently have a $18.00 price target on the stock.

Separately, Wall Street Zen upgraded Alpha Cognition from a “sell” rating to a “hold” rating in a research note on Saturday, November 15th. One research analyst has rated the stock with a Buy rating, According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus price target of $18.00.

Alpha Cognition Price Performance

NASDAQ ACOG opened at $5.56 on Friday. The company’s 50 day simple moving average is $6.14 and its two-hundred day simple moving average is $8.01. Alpha Cognition has a 1 year low of $3.75 and a 1 year high of $11.54. The stock has a market capitalization of $120.87 million, a PE ratio of -4.06 and a beta of 2.62.

Alpha Cognition (NASDAQ:ACOG) last released its quarterly earnings results on Thursday, November 13th. The company reported ($0.30) EPS for the quarter, beating analysts’ consensus estimates of ($0.43) by $0.13. The firm had revenue of $2.84 million for the quarter, compared to analysts’ expectations of $3.21 million.

Hedge Funds Weigh In On Alpha Cognition

A number of large investors have recently modified their holdings of the company. AWM Investment Company Inc. purchased a new stake in Alpha Cognition in the first quarter worth approximately $5,785,000. Cable Car Capital LP boosted its stake in shares of Alpha Cognition by 68.8% in the 2nd quarter. Cable Car Capital LP now owns 869,002 shares of the company’s stock valued at $8,108,000 after purchasing an additional 354,278 shares in the last quarter. Boothbay Fund Management LLC grew its holdings in shares of Alpha Cognition by 10.8% during the 3rd quarter. Boothbay Fund Management LLC now owns 291,868 shares of the company’s stock valued at $1,900,000 after purchasing an additional 28,392 shares during the last quarter. Manatuck Hill Partners LLC raised its position in Alpha Cognition by 74.6% in the 2nd quarter. Manatuck Hill Partners LLC now owns 117,000 shares of the company’s stock worth $1,092,000 after purchasing an additional 50,000 shares during the period. Finally, Marshall Wace LLP purchased a new position in Alpha Cognition in the 2nd quarter worth $600,000.

About Alpha Cognition

Alpha Cognition, Inc is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer’s Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.